Kimberly-Clark de Mexico SAB de CV (OTCMKTS:KCDMY – Get Free Report) posted its quarterly earnings results on Tuesday. The basic materials company reported $0.20 earnings per share for the quarter, meeting the consensus estimate of $0.20, Zacks reports. The business had revenue of $830.35 million during the quarter, compared to analysts’ expectations of $839.55 million. Kimberly-Clark de Mexico SAB de CV had a net margin of 13.92% and a return on equity of 164.99%.
Kimberly-Clark de Mexico SAB de CV Stock Down 0.7%
KCDMY stock traded down $0.07 during mid-day trading on Thursday, reaching $11.12. The company had a trading volume of 4,461 shares, compared to its average volume of 49,659. The firm has a fifty day simple moving average of $10.98 and a 200 day simple moving average of $11.44. The company has a debt-to-equity ratio of 11.44, a quick ratio of 1.36 and a current ratio of 1.55. The company has a market capitalization of $6.84 billion, a price-to-earnings ratio of 15.88 and a beta of 0.67. Kimberly-Clark de Mexico SAB de CV has a fifty-two week low of $8.25 and a fifty-two week high of $12.84.
Analyst Ratings Changes
Separately, HSBC cut shares of Kimberly-Clark de Mexico SAB de CV from a “buy” rating to a “hold” rating in a report on Wednesday, April 29th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.
Kimberly-Clark de Mexico SAB de CV Company Profile
Kimberly-Clark de México, SAB. de C.V. operates as one of the leading manufacturers of personal care and paper‐based products in Mexico. As a locally managed subsidiary of the global Kimberly-Clark Corporation, the company focuses on the production, marketing and distribution of consumer staples designed for everyday use, ranging from facial and bathroom tissue to diapers and feminine care items.
The company’s portfolio includes well-known brands such as Kleenex and Scott for tissue products, Huggies for baby care, Kotex for feminine hygiene and Depend for adult incontinence.
Further Reading
- Five stocks we like better than Kimberly-Clark de Mexico SAB de CV
- The 2026 Blueprint: 6 Stocks for a Brand New Portfolio
- Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken
- Cementing the Sky: Why NVIDIA’s Bet on Nebius Matters
- Forging Profits: The Executive Order Sparking Aluminum
Receive News & Ratings for Kimberly-Clark de Mexico SAB de CV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark de Mexico SAB de CV and related companies with MarketBeat.com's FREE daily email newsletter.
